Hepatic stellate cells

The Liver: Biology and Pathobiology

Volumn , Issue , 2009, Pages 407-432

  Rojkind, Marcos ^a   Reyes Gordillo, Karina ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052285229     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470747919.ch28     Document Type: Chapter

References (373)

1. Rojkind, M. and Greenwel, P. (2001) in Pathophysiology of Liver Fibrosis (eds I.M. Arias, F.V. Boyer, J.L. Chisari, W.B. Fausto, D. Schachter and D.A. Shafritz), Lipcott Press, pp. 721-38.
2. Fausto, N., Campbell, J.S. and Riehle, K.J. (2006) Liver regeneration. Hepatology, 43 (2 Suppl 1), S45-53.
3. Michalopoulos, G.K. (2007) Liver regeneration. J Cell Physiol, 213, 286-300.
4. Gressner, O.A., Rizk, M.S., Kovalenko, E., Weiskirchen, R. and Gressner, A.M. (2008) Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go? J Gastroenterol Hepatol, 23 (7Pt 1), 1024-35.
5. Friedman, S.L. (2008) Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev, 88, 125-72.
6. Somasundaram, R. and Schuppan, D. (1996) Type I, II, III, IV, V, and VI collagens serve as extracellular ligands for the isoforms of platelet-derived growth factor (AA, BB, and AB). J Biol Chem, 271, 26884-91.
7. Schuppan, D., Schmid, M., Somasundaram, R., Ackermann, R., Ruehl, M., Nakamura, T. and Riecken, E.-O. (1998) Collagens in the liver extracellular matrix bind hepatocyte growth factor. Gastroenterology, 114, 139-52.
8. Ruhl, M., Johannsen, M., Atkinson, J., Manski, D., Sahin, E., Somasundaram, R., Riecken, E.O. and Schuppan, D. (1999) Soluble collagen VI induces tyrosine phosphorylation of paxillin and focal adhesion kinase and activates the MAP kinase Erk2 in fibroblasts. Exp Cell Res, 250, 548-57.
9. Somasundaram, R., Ruehl, M., Tiling, N., Ackermann, R., Schmid, M., Riecken, E.O. and Schuppan, D. (2000) Collagens serve as an extracellular store of bioactive interleukin 2. J Biol Chem, 275, 38170-75.
10. Somasundaram, R., Ruehl, M., Schaefer, B., Schmid, M., Ackermann, R., Riecken, E.O., Zeitz, M. and Schuppan, D. (2002) Interstitial collagens I, III, and VI sequester and modulate the multifunctional cytokine oncostatin M. J Biol Chem, 277, 3242-46.
11. Ramirez, F., Carta, L., Lee-Arteaga, S., Liu, C., Nistala, H. and Smaldone, S. (2008) Fibrillin-rich microfibrils-structural and instructive determinants of mammalian development and physiology. Connect Tissue Res, 49, 1-6.
12. Rockey, D.C. (2006) Hepatic fibrosis, stellate cells, and portal hypertension. Clin Liver Dis, 10, 459-79, vii-viii.
13. Gressner, A.M. and Weiskirchen, R. (2006) Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med, 10, 76-99.
14. Parsons, C.J., Takashima, M. and Rippe, R.A. (2007) Molecular mechanisms of hepatic fibrogenesis. J Gastroenterol Hepatol, 22 (Suppl 1), S79-84.
15. Kisseleva, T. and Brenner, D.A. (2007) Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis. J Gastroenterol Hepatol, 22 (Suppl 1), S73-78.
16. Reynaert, H., Urbain, D. and Geerts, A. (2008) Regulation of sinusoidal perfusion in portal hypertension. Anat Rec (Hoboken), 291, 693-98.
17. Friedman, S.L. (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology, 134, 1655-69.
18. Wallace, K., Burt, A.D. and Wright, M.C. (2008) Liver fibrosis. Biochem J, 411, 1-18.
19. Bataller, R. and Brenner, D.A. (2001) Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liver Dis, 21, 437-51.
20. Kisseleva, T. and Brenner, D.A. (2006) Hepatic stellate cells and the reversal of fibrosis. J Gastroenterol Hepatol, 21 (Suppl 3), S84-87.
21. Bueno, M., Salgado, S., Beas-Zárate, C. and Armendariz-Borunda, J. (2006) Urokinase-type plasminogen activator gene therapy in liver cirrhosis is mediated by collagens gene expression down-regulation and up-regulation of MMPs, HGF and VEGF. J Gene Med, 8, 1291-99.
22. Iimuro, Y., Nishio, T., Morimoto, T., Nitta, T., Stefanovic, B., Choi, S.K., Brenner, D.A. and Yamaoka, Y. (2003) Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat. Gastroenterology, 124, 445-58.
23. Siller-López, F., Sandoval, A., Salgado, S., Salazar, A., Bueno, M., Garcia, J., Vera, J., Gálvez, J., Hernández, I., Ramos, M., Aguilar-Cordova, E. and Armendariz-Borunda, J. (2004) Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis. Gastroenterology, 126, 1122-33.
24. Windmeier, C. and Gressner, A.M. (1997) Pharmacological aspects of pentoxifylline with emphasis on its inhibitory actions on hepatic fibrogenesis. Gen Pharmacol, 29, 181-96.
25. Pines, M. and Nagler, A. (1998) Halofuginone: a novel antifibrotic therapy. Gen Pharmacol, 30, 445-50.
26. Wright, M.C., Issa, R., Smart, D.E., Trim, N., Murray, G.I., Primrose, J.N., Arthur, M.J., Iredale, J.P. and Mann, D.A. (2001) Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. Gastroenterology, 121, 685-98.
27. Iredale, J.P. (2001) Hepatic stellate cell behavior during resolution of liver injury. Semin Liver Dis, 21, 427-36.
28. Fallowfield, J.A. and Iredale, J.P. (2004) Targeted treatments for cirrhosis. Expert Opin Ther Targets, 8, 423-35.
29. Bueno, M., Salgado, S., Beas-Zárate, C. and Armendariz-Borunda, J. (2006) Urokinase-type plasminogen activator gene therapy in liver cirrhosis is mediated by collagens gene expression down-regulation and up-regulation of MMPs, HGF and VEGF. J Gene Med, 8, 1291-99.
30. Fowell, A.J. and Iredale, J.P. (2006) Emerging therapies for liver fibrosis. Dig Dis, 24, 174-83.
31. Ueno, T., Nakamura, T., Torimura, T. and Sata, M. (2006) Angiogenic cell therapy for hepatic fibrosis. Med Mol Morphol, 39, 16-21.
32. Popov, Y., Patsenker, E., Bauer, M., Niedobitek, E., Schulze-Krebs, A. and Schuppan, D. (2006) Halofuginone induces matrix metalloproteinases in rat hepatic stellate cells via activation of p38 and NFkappaB. J Biol Chem, 281, 15090-98.
33. Muãoz-Luque, J., Ros, J., Fernández-Varo, G., Tugues, S., Morales-Ruiz, M., Alvarez, C.E., Friedman, S.L., Arroyo, V. and Jiménez, W. (2008) Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats. J Pharmacol Exp Ther, 324, 475-83.
34. Siegmund, S.V. and Schwabe, R.F. (2008) Endocannabinoids and liver disease. II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis. Am J Physiol Gastrointest Liver Physiol, 294, G357-62.
35. Sato, Y., Murase, K., Kato, J., Kobune, M., Sato, T., Kawano, Y., Takimoto, R., Takada, K., Miyanishi, K., Matsunaga, T., Takayama, T. and Niitsu, Y. (2008) Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone. Nat Biotechnol, 26, 431-42.
36. Iimuro, Y. and Brenner, D.A. (2008) Matrix metalloproteinase gene delivery for liver fibrosis. Pharm Res, 25 (2), 249-58.
37. Hernández, E., Bucio, L., Souza, V., Escobar, M.C., Gómez-Quiroz, L.E., Farfán, B., Kershenobich, D. and Gutiérrez-Ruiz, M.C. (2008) Pentoxifylline downregulates alpha (I) collagen expression by the inhibition of Ikappabalpha degradation in liver stellate cells. Cell Biol Toxicol, 24, 303-14.
38. Salazar-Montes, A., Ruiz-Corro, L., López-Reyes, A., Castrejón-Gómez, E. and Armendáriz-Borunda, J. (2008) Potent antioxidant role of pirfenidone in experimental cirrhosis. Eur J Pharmacol, 595, 69-77.
39. George, J., Roulot, D., Koteliansky, V.E. and Bissell, D.M. (1999) In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis. Proc Natl Acad Sci U S A, 96, 12719-24.
40. Ueno, H., Sakamoto, T., Nakamura, T., Qi, Z., Astuchi, N., Takeshita, A., Shimizu, K. and Ohashi, H. (2000) A soluble transforming growth factor beta receptor expressed in muscle prevents liver fibrogenesis and dysfunction in rats. Hum Gene Ther, 11, 33-42.
41. Yata, Y., Gotwals, P., Koteliansky, V. and Rockey, D.C. (2002) Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-beta soluble receptor: implications for antifibrotic therapy. Hepatology, 35, 1022-30.
42. Cui, X., Shimizu, I., Lu, G., Itonaga, M., Inoue, H., Shono, M., Tamaki, K., Fukuno, H., Ueno, H. and Ito, S. (2003) Inhibitory effect of a soluble transforming growth factor beta type II receptor on the activation of rat hepatic stellate cells in primary culture. J Hepatol, 39, 731-37.
43. Ezquerro, I.J., Lasarte, J.J., Dotor, J., Castilla-Cortázar, I., Bustos, M., Peñuelas, I., Blanco, G., Rodríguez, C., Lechuga Mdel, C., Greenwel, P., Rojkind, M., Prieto, J. and Borrás-Cuesta, F. (2003) A synthetic peptide from transforming growth factor beta type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury. Cytokine, 22, 12-20.
44. Rojkind, M. (1973) Inhibition of liver fibrosis by 1-azetidine-2-carboxylic acid in rats treated with carbon tetrachloride. J Clin Invest, 52, 2451-56.
45. Rojkind, M., Uribe, M. and Kershenobich, D. (1973) Colchicine and the treatment of liver cirrhosis. Lancet, i, 38-39.
46. Kershenobich, D., Uribe, M., Suárez, G.I., Mata, J.M., Pérez-Tamayo, R. and Rojkind, M. (1979) Treatment of cirrhosis with colchicine. A double-blind randomized trial. Gastroenterology, 77, 532-36.
47. Rojkind, M., Mourelle, M. and Kershenobich, D. (1984) Antiinflammatory and antifibrogenic activities of colchicine: treatment of liver cirrhosis. Prog Clin Biol Res, 154, 475-89.
48. Kershenobich, D., Vargas, F., Garcia-Tsao, G., Perez Tamayo, R., Gent, M. and Rojkind, M. (1988) Colchicine in the treatment of cirrhosis of the liver. N Engl J Med, 318, 1709-13.
49. Geerts, A. (2001) History, heterogeneity, developmental biology and functions of quiescent hepatic stellate cells. Semin Liver Dis, 21, 311-35.
50. Geerts, A. (2004) On the origin of stellate cells: mesodermal, endodermal or neuro-ectodermal? J Hepatol, 40, 331-34.
51. Martinez-Hernandez, A. (1984) The hepatic extracellular matrix. I. Electron immunohistochemical studies in normal rat liver. Lab Invest, 51, 57.
52. Martinez-Hernandez, A. and Amenta, P.S. (1993) The hepatic extracellular matrix. I. Components and distribution in normal liver. Virchows Arch A Pathol Anat Histopathol, 423 (1), 1-11.
53. Martinez-Hernandez, A. (1985) The hepatic extracellular matrix. II. Electron immunohistochemical studies in rats with CCl4-induced cirrhosis. Lab Invest, 53, 166-86.
54. Greenwel, P., Rubin, J., Schwartz, M., Hertzberg, E.L. and Rojkind, M. (1993) Liver fat-storing cell clones obtained from a CCl4-cirrhotic rat are heterogeneous with regard to proliferation, expression of extracellular matrix components, interleukin-6, and connexin 43. Lab Invest, 69, 210-16.
55. Fischer, R., Reinehr, R., Lu, T.P., Schönicke, A., Warskulat, U., Dienes, H.P. and Häussinger, D. (2005) Intercellular communication via gap junctions in activated rat hepatic stellate cells. Gastroenterology, 128, 433-48.
56. Rojkind, M., Novikoff, P.M., Greenwel, P., Rubin, J., Rojas-Valencia, L., de Carvalho, A.C., Stockert, R., Spray, D., Hertzberg, E.L. and Wolkoff, A.W. (1995) Characterization and functional studies on rat liver fat-storing cell line and freshly isolated hepatocyte coculture system. Am J Pathol, 146, 1508-20.
57. de Leeuw, A.M., McCarthy, S.P., Geerts, A. and Knook, D.L. (1984) Purified rat liver fat-storing cells in culture divide and contain collagen. Hepatology, 4, 392-403.
58. Friedman, S.L., Roll, F.J., Boyles, J. and Bissell, D.M. (1985) Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci U S A, 82, 8681-85.
59. Friedman, S.L. and Roll, F.J. (1987) Isolation and culture of hepatic lipocytes, Kupffer cells, and sinusoidal endothelial cells by density gradient centrifugation with Stractan. Anal Biochem, 161, 207-18.
60. Hendriks, H.F., Brouwer, A. and Knook, D.L. (1987) The role of hepatic fat-storing (stellate) cells in retinoid metabolism. Hepatology, 7, 1368-71.
61. Hellemans, K., Grinko, I., Rombouts, K., Schuppan, D. and Geerts, A. (1999) All-trans and 9-cis retinoic acid alter rat hepatic stellate cell phenotype differentially. Gut, 45, 134-42.
62. Blomhoff, R. and Wake, K. (1991) Perisinusoidal stellate cells of the liver: important roles in retinol metabolism and fibrosis. FASEB J, 5, 271-77.
63. Weiner, F.R., Blaner, W.S., Czaja, M.J., Shah, A. and Geerts, A. (1992) Ito cell expression of a nuclear retinoic acid receptor. Hepatology, 15, 336-42.
64. Hellemans, K., Rombouts, K., Quartier, E., Dittié, A.S., Knorr, A., Michalik, L., Rogiers, V., Schuit, F., Wahli, W. and Geerts, A. (2003) PPARbeta regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation. J Lipid Res, 44, 280-95.
65. Hellemans, K., Verbuyst, P., Quartier, E., Schuit, F., Rombouts, K., Chandraratna, R.A., Schuppan, D. and Geerts, A. (2004) Differential modulation of rat hepatic stellate phenotype by natural and synthetic retinoids. Hepatology, 39, 97-108.
66. Mezaki, Y., Yoshikawa, K., Yamaguchi, N., Miura, M., Imai, K., Kato, S. and Senoo, H. (2007) Rat hepatic stellate cells acquire retinoid responsiveness after activation in vitro by post-transcriptional regulation of retinoic acid receptor alpha gene expression. Arch Biochem Biophys, 465, 370-79.
67. Senoo, H., Kojima, N. and Sato, M. (2007) Vitamin A-storing cells (stellate cells). Vitam Horm, 75, 131-59.
68. Geerts, A., Niki, T., Hellemans, K., De Craemer, D., Van Den Berg, K., Lazou, J.M., Stange, G., Van De Winkel, M. and De Bleser, P. (1998) Purification of rat hepatic stellate cells by side scatter-activated cell sorting. Hepatology, 27, 590-98.
69. Hisamori, S., Tabata, C., Kadokawa, Y., Okoshi, K., Tabata, R., Mori, A., Nagayama, S., Watanabe, G., Kubo, H. and Sakai, Y. (2008) All-trans-retinoic acid ameliorates carbon tetrachloride-induced liver fibrosis in mice through modulating cytokine production. Liver Int, 28, 1217-25.
70. Geubel, A.P., De Galocsy, C., Alves, N., Rahier, J. and Dive, C. (1991) Liver damage caused by therapeutic vitamin A administration: estimate of dose-related toxicity in 41 cases. Gastroenterology, 100, 1701-9.
71. Hendriks, H.F., Bosma, A. and Brouwer, A. (1993) Fat-storing cells: hyper- and hypovitaminosis A and the relationships with liver fibrosis. Semin Liver Dis, 13, 72-80.
72. Friedman, S.L. (2000) Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem, 275, 2247-2250.
73. Nollevaux, M.C., Guiot, Y., Horsmans, Y., Leclercq, I., Rahier, J., Geubel, A.P. and Sempoux, C. (2006) Hypervitaminosis A-induced liver fibrosis: stellate cell activation and daily dose consumption. Liver Int, 26, 182-86.
74. Wang, L., Potter, J.J., Rennie-Tankersley, L., Novitskiy, G., Sipes, J. and Mezey, E. (2007) Effects of retinoic acid on the development of liver fibrosis produced by carbon tetrachloride in mice. Biochim Biophys Acta, 1772, 66-71.
75. Jorens, P.G., Michielsen, P.P., Pelckmans, P.A., Fevery, J., Desmet, V.J., Geubel, A.P., Rahier, J. and Van Maercke, Y.M. (1992) Vitamin A abuse: development of cirrhosis despite cessation of vitamin A. A six-year clinical and histopathologic follow-up. Liver, 12, 381-86.
76. Rockey, D.C. (2001) Hepatic blood flow regulation by stellate cells in normal and injured liver. Semin Liver Dis, 21, 337-49.
77. McCuskey, R.S. (2008) The hepatic microvascular system in health and its response to toxicants. Anat Rec (Hoboken), 291, 661-71.
78. Thimgan, M.S. and Yee, H.F. Jr. (1999) Quantitation of rat hepatic stellate cell contraction: stellate cells’ contribution to sinusoidal resistance. Am J Physiol, 277 (1Pt 1), G137-43.
79. Bataller, R., Nicolás, J.M., Gineès, P., Görbig, M.N., Garcia-Ramallo, E., Lario, S., Tobías, E., Pinzani, M., Thomas, A.P., Arroyo, V. and Rodés, J. (1998) Contraction of human hepatic stellate cells activated in culture: a role for voltage-operated calcium channels. J Hepatol, 29, 398-408.
80. Wirz, W., Antoine, M., Tag, C.G., Gressner, A.M., Korff, T., Hellerbrand, C. and Kiefer, P. (2008) Hepatic stellate cells display a functional vascular smooth muscle cell phenotype in a three-dimensional co-culture model with endothelial cells. Differentiation, 76, 784-94.
81. Desmoulière, A., Chaponnier, C. and Gabbiani, G. (2005) Tissue repair, contraction, and the myofibroblast. Wound Repair Regen, 13, 7-12.
82. Kmieć, Z. (2001) Cooperation of liver cells in health and disease. Adv Anat Embryol Cell Biol, 161, 1-151.
83. Soon, R.K. Jr. and Yee, H.F. Jr. (2008) Stellate cell contraction: role, regulation, and potential therapeutic target. Clin Liver Dis, 12, 791-803.
84. Kharbanda, K.K., Rogers, D.D. II, Wyatt, T.A., Sorrell, M.F. and Tuma, D.J. (2004) Transforming growth factor-beta induces contraction of activated hepatic stellate cells. J Hepatol, 41, 60-66.
85. Kawada, N., Tran-Thi, T.A., Klein, H. and Decker, K. (1993) The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. Eur J Biochem, 213, 815-23.
86. Kawada, N., Seki, S., Kuroki, T. and Kaneda, K. (1999) ROCK inhibitor Y-27632 attenuates stellate cell contraction and portal pressure increase induced by endothelin-1. Biochem Biophys Res Commun, 266, 296-300.
87. Saab, S., Tam, S.P., Tran, B.N., Melton, A.C., Tangkijvanich, P., Wong, H. and Yee, H.F. Jr. (2002) Myosin mediates contractile force generation by hepatic stellate cells in response to endothelin-1. J Biomed Sci, 9 (6Pt 2), 607-12.
88. Melton, A.C., Datta, A. and Yee, H.F. Jr. (2006) [Ca2+]i-independent contractile force generation by rat hepatic stellate cells in response to endothelin-1. Am J Physiol Gastrointest Liver Physiol, 290, G7-13.
89. Bataller, R., Ginès, P., Nicolás, J.M., Görbig, M.N., Garcia-Ramallo, E., Gasull, X., Bosch, J., Arroyo, V. and Rodés, J. (2000) Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology, 118, 1149-56.
90. Yanase, M., Ikeda, H., Matsui, A., Maekawa, H., Noiri, E., Tomiya, T., Arai, M., Yano, T., Shibata, M., Ikebe, M., Fujiwara, K., Rojkind, M. and Ogata, I. (2000) Lysophosphatidic acid enhances collagen gel contraction by hepatic stellate cells: association with rhokinase. Biochem Biophys Res Commun, 277, 72-78.
91. Yee, H.F. Jr. (1998) Rho directs activation-associated changes in rat hepatic stellate cell morphology via regulation of the actin cytoskeleton. Hepatology, 28, 843-50.
92. Yanase, M., Ikeda, H., Ogata, I., Matsui, A., Noiri, E., Tomiya, T., Arai, M., Inoue, Y., Tejima, K., Nagashima, K., Nishikawa, T., Shibata, M., Ikebe, M., Rojkind, M. and Fujiwara, K. (2003) Functional diversity between Rho-kinase- and MLCK-mediated cytoskeletal actions in a myofibroblast-like hepatic stellate cell line. Biochem Biophys Res Commun, 305, 223-28.
93. Trebicka, J., Hennenberg, M., Laleman, W., Shelest, N., Biecker, E., Schepke, M., Nevens, F., Sauerbruch, T. and Heller, J. (2007) Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase. Hepatology, 46, 242-53.
94. Lang, A., Schrum, L.W., Schoonhoven, R., Tuvia, S., Solís-Herruzo, J.A., Tsukamoto, H., Brenner, D.A. and Rippe, R.A. (2000) Expression of small heat shock protein alphaB-crystallin is induced after hepatic stellate cell activation. Am J Physiol Gastrointest Liver Physiol, 279, G1333-42.
95. Cassiman, D., Roskams, T., van Pelt, J., Libbrecht, L., Aertsen, P., Crabbé, T., Vankelecom, H. and Denef, C. (2001) Alpha B-crystallin expression in human and rat hepatic stellate cells. J Hepatol, 35, 200-7.
96. Cassiman, D., Denef, C., Desmet, V.J. and Roskams, T. (2001) Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors. Hepatology, 33, 148-58.
97. Gard, A.L., White, F.P. and Dutton, G.R. (1985) Extra-neural glial fibrillary acidic protein (GFAP) immunoreactivity in perisinusoidal stellate cells of rat liver. J Neuroimmunol, 8, 359-75.
98. Murphy, F., Waung, J., Collins, J., Arthur, M.J., Nagase, H., Mann, D., Benyon, R.C. and Iredale, J.P. (2004) N-Cadherin cleavage during activated hepatic stellate cell apoptosis is inhibited by tissue inhibitor of metalloproteinase-1. Comp Hepatol, 3 (Suppl 1), S8.
99. Niki, T., Pekny, M., Hellemans, K., Bleser, P.D., Berg, K.V., Vaeyens, F., Quartier, E., Schuit, F. and Geerts, A. (1999) Class VI intermediate filament protein nestin is induced during activation of rat hepatic stellate cells. Hepatology, 29, 520-27.
100. Knittel, T., Aurisch, S., Neubauer, K., Eichhorst, S. and Ramadori, G. (1996) Cell-type-specific expression of neural cell adhesion molecule (N-CAM) in Ito cells of rat liver. Up-regulation during in vitro activation and in hepatic tissue repair. Am J Pathol, 149, 449-62.
101. Nakatani, K., Seki, S., Kawada, N., Kobayashi, K. and Kaneda, K. (1996) Expression of neural cell adhesion molecule (N-CAM) in perisinusoidal stellate cells of the human liver. Cell Tissue Res, 283, 159-65.
102. Zhou, X.F. and Rush, R.A. (1993) Localization of neurotrophin-3-like immunoreactivity in peripheral tissues of the rat. Brain Res, 621, 189-99.
103. Kanda, N., Fukuda, Y., Imoto, M., Koyama, Y., Nakano, I. and Urano, F. (1994) Localization of synaptophysin immunoreactivity in the human liver. Scand J Gastroenterol, 29, 275-79.
104. Cassiman, D., van Pelt, J., De Vos, R., Van Lommel, F., Desmet, V., Yap, S.H. and Roskams, T. (1999) Synaptophysin: a novel marker for human and rat hepatic stellate cells. Am J Pathol, 155, 1831-39.
105. Sicklick, J.K., Choi, S.S., Bustamante, M., McCall, S.J., Pérez, E.H., Huang, J., Li, Y.X., Rojkind, M. and Diehl, A.M. (2006) Evidence for epithelial-mesenchymal transitions in adult liver cells. Am J Physiol Gastrointest Liver Physiol, 291, G575-83.
106. Lim, Y.S., Kim, K.A., Jung, J.O., Yoon, J.H., Suh, K.S., Kim, C.Y. and Lee, H.S. (2002) Evidence of transdifferentiation from epithelial to mesenchymal phenotype. Histochem Cell Biol, 118, 127-36.
107. Lim, Y.S., Lee, H.C. and Lee, H.S. (2007) Switch of cadherin expression from E- to N-type during the activation of rat hepatic stellate cells. Histochem Cell Biol, 127, 149-60.
108. Mermelstein, C.S., Guma, F.C., Mello, T.G., Fortuna, V.A., Guaragna, R.M., Costa, M.L. and Borojevic, R. (2001) Induction of the lipocyte phenotype in murine hepatic stellate cells: reorganization of the actin cytoskeleton. Cell Tissue Res, 306, 75-83.
109. Ramadori, G., Veit, T., Schwögler, S., Dienes, H.P., Knittel, T., Rieder, H. and Meyer zum Büschenfelde, K.H. (1990) Expression of the gene of the alpha-smooth muscle-actin isoform in rat liver and in rat fat-storing (ITO) cells. Virchows Arch B Cell Pathol Incl Mol Pathol, 59, 349-57.
110. Schmitt-Gräff, A., Krüger, S., Bochard, F., Gabbiani, G. and Denk, H. (1991) Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers. Am J Pathol, 138, 1233-42.
111. Burt, A.D., Robertson, J.L., Heir, J. and MacSween, R.N. (1986) Desmin-containing stellate cells in rat liver; distribution in normal animals and response to experimental acute liver injury. J Pathol, 150, 29-35.
112. Ogata, I., Sáez, C.G., Greenwel, P., Ponce Mde, L., Geerts, A., Leinwand, L.A. and Rojkind, M. (1993) Rat liver fat-storing cell lines express sarcomeric myosin heavy chain mRNA and protein. Cell Motil Cytoskeleton, 26, 125-32.
113. Mayer, D.C. and Leinwand, L.A. (1997) Sarcomeric gene expression and contractility in myofibroblasts. J Cell Biol, 139, 1477-784.
114. Kisseleva, T., Uchinami, H., Feirt, N., Quintana-Bustamante, O., Segovia, J.C., Schwabe, R.F. and Brenner, D.A. (2006) Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol, 45, 429-38.
115. Mullhaupt, B., Feren, A., Fodor, E. and Jones, A. (1994) Liver expression of epidermal growth factor RNA. Rapid increases in immediate-early phase of liver regeneration. J Biol Chem, 269, 19667-70.
116. Marra, F., Choudhury, G.G., Pinzani, M. and Abboud, H.E. (1994) Regulation of platelet-derived growth factor secretion and gene expression in human liver fat-storing cells. Gastroenterology, 107, 1110-17.
117. Breitkopf, K., Roeyen, C., Sawitza, I., Wickert, L., Floege, J. and Gressner, A.M. (2005) Expression patterns of PDGF-A, -B, -C and -D and the PDGF-receptors alpha and beta in activated rat hepatic stellate cells (HSC). Cytokine, 31, 349-57.
118. Ramadori, G., Neubauer, K., Odenthal, M., Nakamura, T., Knittel, T., Schwögler, S. and Meyer zum Büschenfelde, K.H. (1992) The gene of hepatocyte growth factor is expressed in fat-storing cells of rat liver and is downregulated during cell growth and by transforming growth factor-beta. Biochem Biophys Res Commun, 183, 739-42.
119. Schirmacher, P., Geerts, A., Pietrangelo, A., Dienes, H.P. and Rogler, C.E. (1992) Hepatocyte growth factor/hepatopoietin A is expressed in fat-storing cells from rat liver but not myofibroblast-like cells derived from fat-storing cells. Hepatology, 15, 5-11.
120. Evarts, R.P., Hu, Z., Fujio, K., Marsden, E.R. and Thorgeirsson, S.S. (1993) Activation of hepatic stem cell compartment in the rat: role of transforming growth factor alpha, hepatocyte growth factor, and acidic fibroblast growth factor in early proliferation. Cell Growth Differ, 4, 555-61.
121. Skrtic, S., Wallenius, V., Ekberg, S., Brenzel, A., Gressner, A.M. and Ansson, J.O. (1997) Insulin-like growth factors stimulate expression of hepatocyte growth factor but not transforming growth factor beta1 in cultured hepatic stellate cells. Endocrinology, 138, 4683-89.
122. Skrtic, S., Wallenius, V., Ekberg, S., Brenzel, A., Gressner, A.M. and Jansson, J.O. (1999) Hepatocyte-stimulated expression of hepatocyte growth factor (HGF) in cultured rat hepatic stellate cells. J Hepatol, 30, 115-24.
123. Tomiya, T., Inoue, Y., Yanase, M., Arai, M., Ikeda, H., Tejima, K., Nagashima, K., Nishikawa, T. and Fujiwara, K. (2002) Leucine stimulates the secretion of hepatocyte growth factor by hepatic stellate cells. Biochem Biophys Res Commun, 297, 1108-11.
124. Barnaeva, E., Nadezhda, A., Hannappel, E., Sjogren, M.H. and Rojkind, M. (2007) Thymosin beta4 upregulates the expression of hepatocyte growth factor and downregulates the expression of PDGF-beta receptor in human hepatic stellate cells. Ann N Y Acad Sci, 1112, 154-60.
125. Marsden, E.R., Hu, Z., Fujio, K., Nakatsukasa, H., Thorgeirsson, S.S. and Evarts, R.P. (1992) Expression of acidic fibroblast growth factor in regenerating liver and during hepatic differentiation. Lab Invest, 67, 427-33.
126. Antoine, M., Wirz, W., Tag, C.G., Gressner, A.M., Marvituna, M., Wycislo, M., Hellerbrand, C. and Kiefer, P. (2007) Expression and function of fibroblast growth factor (FGF) 9 in hepatic stellate cells and its role in toxic liver injury. Biochem Biophys Res Commun, 361, 335-41.
127. Williams, E.J., Gaça, M.D., Brigstock, D.R., Arthur, M.J. and Benyon, R.C. (2000) Increased expression of connective tissue growth factor in fibrotic human liver and in activated hepatic stellate cells. J Hepatol, 32, 754-61.
128. Paradis, V., Dargere, D., Bonvoust, F., Vidaud, M., Segarini, P. and Bedossa, P. (2002) Effects and regulation of connective tissue growth factor on hepatic stellate cells. Lab Invest, 82, 767-74.
129. Gao, R. and Brigstock, D.R. (2003) Low density lipoprotein receptor-related protein (LRP) is a heparin-dependent adhesion receptor for connective tissue growth factor (CTGF) in rat activated hepatic stellate cells. Hepatol Res, 27, 214-20.
130. Gao, R. and Brigstock, D.R. (2004) Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin alpha(v)beta(3) and heparan sulfate proteoglycan. J Biol Chem, 279, 8848-55.
131. Gao, R., Ball, D.K., Perbal, B. and Brigstock, D.R. (2004) Connective tissue growth factor induces c-fos gene activation and cell proliferation through p44/42 MAP kinase in primary rat hepatic stellate cells. J Hepatol, 40, 431-38.
132. Gressner, O.A., Lahme, B., Demirci, I., Gressner, A.M. and Weiskirchen, R. (2007) Differential effects of TGF-beta on connective tissue growth factor (CTGF/CCN2) expression in hepatic stellate cells and hepatocytes. J Hepatol, 47, 699-710.
133. Pinzani, M., Abboud, H.E. and Aron, D.C. (1990) Secretion of insulin-like growth factor-I and binding proteins by rat liver fat-storing cells: regulatory role of platelet-derived growth factor. Endocrinology, 127, 2343-49.
134. Scharf, J.G., Knittel, T., Dombrowski, F. et al. (1998) Characterization of the IGF axis components in isolated rat hepatic stellate cells. Hepatology, 27, 1275-84.
135. Sanz, S., Pucilowska, J.B., Liu, S., Rodríguez-Ortigosa, C.M., Lund, P.K., Brenner, D.A., Fuller, C.R., Simmons, J.G., Pardo, A., Martínez-Chantar, M.L., Fagin, J.A. and Prieto, J. (2005) Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury. Gut, 54, 134-41.
136. Chen, A. and Zheng, S. (2008) Curcumin inhibits connective tissue growth factor gene expression in activated hepatic stellate cells in vitro by blocking NF-kappaB and ERK signalling. Br J Pharmacol, 153, 557-67.
137. Yasuda, H., Imai, E., Shiota, A., Fujise, N., Morinaga, T. and Higashio, K. (1996) Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Hepatology, 24, 636-42.
138. Matsuda, Y., Matsumoto, K., Yamada, A., Ichida, T., Asakura, H., Komoriya, Y., Nishiyama, E. and Nakamura, T. (1997) Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis. Hepatology, 26, 81-89.
139. Ueki, T., Kaneda, Y., Tsutsui, H., Nakanishi, K., Sawa, Y., Morishita, R., Matsumoto, K., Nakamura, T., Takahashi, H., Okamoto, E. and Fujimoto, J. (1999) Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med, 5, 226-30.
140. Xia, J.L., Dai, C., Michalopoulos, G.K. and Liu, Y. (2006) Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation. Am J Pathol, 168, 1500-12.
141. Asano, Y., Iimuro, Y., Son, G., Hirano, T. and Fujimoto, J. (2007) Hepatocyte growth factor promotes remodeling of murine liver fibrosis, accelerating recruitment of bone marrow-derived cells into the liver. Hepatol Res, 37, 1080-94.
142. Kanemura, H., Iimuro, Y., Takeuchi, M., Ueki, T., Hirano, T., Horiguchi, K., Asano, Y. and Fujimoto, J. (2008) Hepatocyte growth factor gene transfer with naked plasmid DNA ameliorates dimethylnitrosamineinduced liver fibrosis in rats. Hepatol Res, 38, 930-39.
143. Borkham-Kamphorst, E., Stoll, D., Gressner, A.M. and Weiskirchen, R. (2004) Antisense strategy against PDGF B-chain proves effective in preventing experimental liver fibrogenesis. Biochem Biophys Res Commun, 321, 413-23.
144. Borkham-Kamphorst, E., Stoll, D., Gressner, A.M. and Weiskirchen, R. (2004) Inhibitory effect of soluble PDGF-beta receptor in culture-activated hepatic stellate cells. Biochem Biophys Res Commun, 317, 451-62.
145. Borkham-Kamphorst, E., Herrmann, J., Stoll, D., Treptau, J., Gressner, A.M. and Weiskirchen, R. (2004) Dominant-negative soluble PDGF-beta receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis. Lab Invest, 84, 766-77.
146. Campbell, J.S., Hughes, S.D., Gilbertson, D.G., Palmer, T.E., Holdren, M.S., Haran, A.C., Odell, M.M., Bauer, R.L., Ren, H.P., Haugen, H.S., Yeh, M.M. and Fausto, N. (2005) Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. Proc Natl Acad Sci U S A, 102, 3389-94.
147. Thieringer, F., Maass, T., Czochra, P., Klopcic, B., Conrad, I., Friebe, D., Schirmacher, P., Lohse, A.W., Blessing, M., Galle, P.R., Teufel, A. and Kanzler, S. (2008) Spontaneous hepatic fibrosis in transgenic mice overexpressing PDGF-A. Gene, 423, 23-28.
148. Gressner, A.M., Weiskirchen, R., Breitkopf, K. and Dooley, S. (2002) Roles of TGF-beta in hepatic fibrosis. Front Biosci, 7, d793-807.
149. Greenwel, P., Schwartz, M., Rosas, M., Peyrol, S., Grimaud, J.A. and Rojkind, M. (1991) Characterization of fat-storing cell lines derived from normal and CCl4-cirrhotic livers. Differences in the production of interleukin-6. Lab Invest, 65, 644-53.
150. Tiggelman, A.M., Boers, W., Linthorst, C., Brand, H.S., Sala, M. and Chamuleau, R.A. (1995) Interleukin-6 production by human liver (myo)fibroblasts in culture. Evidence for a regulatory role of LPS, IL-1 beta and TNF alpha. J Hepatol, 23, 295-306.
151. Smart, D.E., Vincent, K.J., Arthur, M.J., Eickelberg, O., Castellazzi, M., Mann, J. and Mann, D.A. (2001) JunD regulates transcription of the tissue inhibitor of metalloproteinases-1 and interleukin-6 genes in activated hepatic stellate cells. J Biol Chem, 276, 24414-21.
152. Greenwel, P. and Rojkind, M. (1997) Accelerated development of liver fibrosis in CCl4-treated rats by the weekly induction of acute phase response episodes: upregulation of alpha1(I) procollagen and tissue inhibitor of metalloproteinase-1 mRNAs. Biochim Biophys Acta, 1361, 177-84.
153. Nieto, N., Dominguez-Rosales, J.A., Fontana, L., Salazar, A., Armendariz-Borunda, J., Greenwel, P. and Rojkind, M. (2001) Rat hepatic stellate cells contribute to the acute-phase response with increased expression of alpha1(I) and alpha1(IV) collagens, tissue inhibitor of metalloproteinase-1, and matrix-metalloproteinase-2 messenger RNAs. Hepatology, 33, 597-607.
154. Wang, S.C., Ohata, M., Schrum, L., Rippe, R.A. and Tsukamoto, H. (1998) Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells. J Biol Chem, 273, 302-8.
155. Thompson, K.C., Trowern, A., Fowell, A., Marathe, M., Haycock, C., Arthur, M.J. and Sheron, N. (1998) Primary rat and mouse hepatic stellate cells express the macrophage inhibitor cytokine interleukin-10 during the course of activation in vitro. Hepatology, 28, 1518-24.
156. Thompson, K., Maltby, J., Fallowfield, J., McAulay, M., Millward-Sadler, H. and Sheron, N. (1998) Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis. Hepatology, 28, 1597-606.
157. Le Moine, O., Louis, H., Sermon, F., Goldman, M. and Devière, J. (1999) Interleukin-10 and liver diseases. Acta Gastroenterol Belg, 62, 1-8.
158. Louis, H., Le Moine, O., Goldman, M. and Devière, J. (2003) Modulation of liver injury by interleukin-10. Acta Gastroenterol Belg, 66, 7-14.
159. Louis, H., Van Laethem, J.L., Wu, W., Quertinmont, E., Degraef, C., Van den Berg, K., Demols, A., Goldman, M., Le Moine, O., Geerts, A. and Devière, J. (1998) Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice. Hepatology, 28, 1607-15.
160. Aurich, H., Sgodda, M., Kaltwaßer, P., Vetter, M., Weise, A., Liehr, T., Brulport, M., Hengstler, J.G., Dollinger, M.M., Fleig, W.E. and Christ, B. (2008) Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo. Gut [Epub ahead of print].
161. Deng, X., Chen, Y.X., Zhang, X., Zhang, J.P., Yin, C., Yue, H.Y., Lin, Y., Han, Z.G. and Xie, W.F. (2008) Hepatic stellate cells modulate the differentiation of bone marrow mesenchymal stem cells into hepatocyte-like cells. J Cell Physiol, 217, 138-44.
162. Deleve, L.D., Wang, X. and Guo, Y. (2008) Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence. Hepatology, 48, 920-30.
163. Taura, K., DeMinicis, S., Seki, E., Hatano, E., Iwaisako, K., Osterreicher, C.H., Kodama, Y., Miura, K., Ikai, I., Uemoto, S. and Brenner, D.A. (2008) Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis. Gastroenterology, 135, 1729-38.
164. Witek, R.P., Yang, L., Liu, R., Jung, Y., Omenetti, A., Syn, W.K., Choi, S.S., Cheong, Y., Fearing, C.M., Agboola, K.M., Chen, W. and Diehl, A.M. (2009) Liver cell-derived microparticles activate hedgehog signaling and alter gene expression in hepatic endothelial cells. Gastroenterology, 136 (1), 320-30.
165. Shen, H., Zhang, M., Kaita, K., Minuk, G.Y., Rempel, J. and Gong, Y. (2005) Expression of Fc fragment receptors of immunoglobulin G (Fc gammaRs) in rat hepatic stellate cells. Dig Dis Sci, 50, 181-87.
166. Winau, F., Hegasy, G., Weiskirchen, R., Weber, S., Cassan, C., Sieling, P.A., Modlin, R.L., Liblau, R.S., Gressner, A.M. and Kaufmann, S.H. (2007) Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity, 26, 117-29.
167. Maubach, G., Lim, M.C., Kumar, S. and Zhuo, L. (2007) Expression and upregulation of cathepsin S and other early molecules required for antigen presentation in activated hepatic stellate cells upon IFN-gamma treatment. Biochim Biophys Acta, 1773, 219-31.
168. Winau, F., Quack, C., Darmoise, A. and Kaufmann, S.H. (2008) Starring stellate cells in liver immunology. Curr Opin Immunol, 20, 8-74.
169. Czaja, M.J., Geerts, A., Xu, J., Schmiedeberg, P. and Ju, Y. (1994) Monocyte chemoattractant protein 1 (MCP-1) expression occurs in toxic rat liver injury and human liver disease. J Leukoc Biol, 55, 120-26.
170. Marra, F., Grandaliano, G., Valente, A.J. and Abboud, H.E. (1995) Thrombin stimulates proliferation of liver fat-storing cells and expression of monocyte chemotactic protein-1: potential role in liver injury. Hepatology, 22, 780-87.
171. Xu, Y., Rojkind, M. and Czaja, M.J. (1996) Regulation of monocyte chemoattractant protein 1 by cytokines and oxygen free radicals in rat hepatic fat-storing cells. Gastroenterology, 110, 1870-77.
172. Nanji, A.A. (2002) Role of Kupffer cells in alcoholic hepatitis. Alcohol, 27, 13-15.
173. Bilzer, M., Roggel, F. and Gerbes, A.L. (2006) Role of Kupffer cells in host defense and liver disease. Liver Int, 26, 1175-86.
174. Cubero, F.J. and Nieto, N. (2006) Kupffer cells and alcoholic liver disease. Rev Esp Enferm Dig, 98, 460-72.
175. Cubero, F.J. and Nieto, N. (2008) Ethanol and arachidonic acid synergize to activate Kupffer cells and modulate the fibrogenic response via tumor necrosis factor alpha, reduced glutathione, and transforming growth factor beta-dependent mechanisms. Hepatology, 48, 2027-39.
176. Seki, E., De Minicis, S., Osterreicher, C.H., Kluwe, J., Osawa, Y., Brenner, D.A. and Schwabe, R.F. (2007) TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med, 13, 1324-12.
177. Seki, E. and Brenner, D.A. (2008l) Toll-like receptors and adaptor molecules in liver disease: update. Hepatology, 48, 322-35.
178. Sprenger, H., Kaufmann, A., Garn, H., Lahme, B., Gemsa, D. and Gressner, A.M. (1997) Induction of neutrophil-attracting chemokines in transforming rat hepatic stellate cells. Gastroenterology, 113, 277-85.
179. Maher, J.J., Lozier, J.S. and Scott, M.K. (1998) Rat hepatic stellate cells produce cytokine-induced neutrophil chemoattractant in culture and in vivo. Am J Physiol, 275 (4Pt 1), G847-53.
180. Kharbanda, K.K., Todero, S.L., Shubert, K.A., Sorrell, M.F. and Tuma, D.J. (2001) Malondialdehydeacetaldehyde-protein adducts increase secretion of chemokines by rat hepatic stellate cells. Alcohol, 25, 123-28.
181. Krizhanovsky, V., Yon, M., Dickins, R.A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L. and Lowe, S.W. (2008) Senescence of activated stellate cells limits liver fibrosis. Cell, 134, 657-67.
182. Kisseleva, T. and Brenner, D.A. (2008) Fibrogenesis of parenchymal organs. Proc Am Thorac Soc, 5, 338-42.
183. Kisseleva, T. and Brenner, D.A. (2008) Mechanisms of fibrogenesis. Exp Biol Med (Maywood), 233, 109-22.
184. Friedman, S.L. (2006) Transcriptional regulation of stellate cell activation. J Gastroenterol Hepatol, 21 (Suppl 3), S79-83.
185. Guo, J. and Friedman, S.L. (2007) Hepatic fibrogenesis. Semin Liver Dis, 27, 413-26.
186. Wtanabe, N., Takashimizu, S., Nishizaki, Y., Kojima, S., Kagawa, T. and Matsuzaki, S. (2007) An endothelin A receptor antagonist induces dilatation of sinusoidal endothelial fenestrae: implications for endothelin-1 in hepatic microcirculation. J Gastroenterol, 42 (9), 775-82.
187. De Minicis, S., Seki, E., Uchinami, H., Kluwe, J., Zhang, Y., Brenner, D.A. and Schwabe, R.F. (2007) Gene expression profiles during hepatic stellate cell activation in culture and in vivo. Gastroenterology, 132, 1937-46.
188. Rojkind, M., Domínguez-Rosales, J.A., Nieto, N. and Greenwel, P. (2002) Role of hydrogen peroxide and oxidative stress in healing responses. Cell Mol Life Sci, 59, 1872-91.
189. Domínguez-Rosales, J.A., Mavi, G., Levenson, S.M. and Rojkind, M. (2000) H(2)O(2) is an important mediator of physiological and pathological healing responses. Arch Med Res, 31, 15-20.
190. Chen, A. and Davis, B.H. (1999) UV irradiation activates JNK and increases alphaI(I) collagen gene expression in rat hepatic stellate cells. J Biol Chem, 274, 158-64.
191. Bahr, M.J., Vincent, K.J., Arthur, M.J., Fowler, A.V., Smart, D.E., Wright, M.C., Clark, I.M., Benyon, R.C., Iredale, J.P. and Mann, D.A. (1999) Control of the tissue inhibitor of metalloproteinases-1 promoter in culture-activated rat hepatic stellate cells: regulation by activator protein-1 DNA binding proteins. Hepatology, 29, 839-48.
192. Mann, D.A. and Smart, D.E. (2002) Transcriptional regulation of hepatic stellate cell activation. Gut, 50, 891-96.
193. Rippe, R.A. and Brenner, D.A. (2004) From quiescence to activation: gene regulation in hepatic stellate cells. Gastroenterology, 127, 1260-62.
194. Smart, D.E., Green, K., Oakley, F., Weitzman, J.B., Yaniv, M., Reynolds, G., Mann, J., Millward-Sadler, H. and Mann, D.A. (2006) JunD is a profibrogenic transcription factor regulated by Jun N-terminal kinaseindependent phosphorylation. Hepatology, 44, 1432-40.
195. García-Trevijano, E.R., Iraburu, M.J., Fontana, L., Domínguez-Rosales, J.A., Auster, A., Covarrubias-Pinedo, A. and Rojkind, M. (1999) Transforming growth factor beta1 induces the expression of alpha1 (I) procollagen mRNA by a hydrogen peroxide-C/EBPbeta-dependent mechanism in rat hepatic stellate cells. Hepatology, 29, 960-70.
196. Greenwel, P., Domínguez-Rosales, J.A., Mavi, G., Rivas-Estilla, A.M. and Rojkind, M. (2000) Hydrogen peroxide: a link between acetaldehyde-elicited alpha1(I) collagen gene up-regulation and oxidative stress in mouse hepatic stellate cells. Hepatology, 31, 109-16.
197. Iraburu, M.J., Domínguez-Rosales, J.A., Fontana, L., Auster, A., García-Trevijano, E.R., Covarrubias-Pinedo, A., Rivas-Estilla, A.M., Greenwel, P. and Rojkind, M. (2000) Tumor necrosis factor alpha down-regulates expression of the alpha1(I) collagen gene in rat hepatic stellate cells through a p20C/EBPbeta- and C/EBPdeltadependent mechanism. Hepatology, 31, 1086-93.
198. Huang, G.C., Zhang, J.S. and Tang, Q.Q. (2004) Involvement of C/EBP-alpha gene in in vitro activation of rat hepatic stellate cells. Biochem Biophys Res Commun, 324, 1309-18.
199. Buck, M. and Chojkier, M. (2007) C/EBPbeta associates with caspase 8 complex proteins and modulates apoptosis in hepatic stellate cells. J Clin Gastroenterol, 41 (Suppl 3), S295-99.
200. Lee, K.S., Buck, M., Houglum, K. and Chojkier, M. (1995) Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest, 96, 2461-68.
201. Weiner, J.A., Chen, A. and Davis, B.H. (1998) E-box-binding repressor is down-regulated in hepatic stellate cells during up-regulation of mannose 6-phosphate/insulin-like growth factor-II receptor expression in early hepatic fibrogenesis. J Biol Chem, 273, 15913-19.
202. Weiner, J.A., Chen, A. and Davis, B.H. (2000) Platelet-derived growth factor is a principal inductive factormodulating mannose 6-phosphate/insulin-like growth factor-II receptorgene expression via a distal E-box in activated hepatic stellate cells. Biochem J, 345 (Pt 2), 225-31.
203. Buck, M., Kim, D.J., Houglum, K., Hassanein, T. and Chojkier, M. (2000) c-Myb modulates transcription of the alpha-smooth muscle actin gene in activated hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol, 278, G321-28.
204. Vincent, K.J., Jones, E., Arthur, M.J., Smart, D.E., Trim, J., Wright, M.C. and Mann, D.A. (2001) Regulation of E-box DNA binding during in vivo and in vitro activation of rat and human hepatic stellate cells. Gut, 49, 713-19.
205. Svegliati-Baroni, G., Inagaki, Y., Rincon-Sanchez, A.R., Else, C., Saccomanno, S., Benedetti, A., Ramirez, F. and Rojkind, M. (2005) Early response of alpha2(I) collagen to acetaldehyde in human hepatic stellate cells is TGF-beta independent. Hepatology, 42, 343-52.
206. Rippe, R.A., Almounajed, G. and Brenner, D.A. (1995) Sp1 binding activity increases in activated Ito cells. Hepatology, 22, 241-51.
207. Inagaki, Y., Truter, S., Greenwel, P., Rojkind, M., Unoura, M., Kobayashi, K. and Ramirez, F. (1995) Regulation of the alpha 2(I) collagen gene transcription in fat-storing cells derived from a cirrhotic liver. Hepatology, 22, 573-79.
208. Kim, Y., Ratziu, V., Choi, S.G., Lalazar, A., Theiss, G., Dang, Q., Kim, S.J. and Friedman, S.L. (1998) Transcriptional activation of transforming growth factor beta1 and its receptors by the Kruppel-like factor Zf9/core promoter-binding protein and Sp1. Potential mechanisms for autocrine fibrogenesis in response to injury. J Biol Chem, 273, 33750-58.
209. Ruiz, I.G., de la Torre, P., Diaz, T., Esteban, E., Morillas, J.D., Muñoz-Yagüe, T. and Solís-Herruzo, J.A. (2000) Sp family of transcription factors is involved in iron-induced collagen alpha1(I) gene expression. DNA Cell Biol, 19, 167-78.
210. Inagaki, Y., Nemoto, T., Nakao, A., ten Dijke, P., Kobayashi, K., Takehara, K. and Greenwel, P. (2001) Interaction between GC box binding factors and Smad proteins modulates cell lineage-specific alpha 2(I) collagen gene transcription. J Biol Chem, 276, 16573-79.
211. García-Ruiz, I., de la Torre, P., Díaz, T., Esteban, E., Fernández, I., Muñoz-Yagüe, T. and Solís-Herruzo, J.A. (2002) Sp1 and Sp3 transcription factors mediate malondialdehyde-induced collagen alpha 1(I) gene expression in cultured hepatic stellate cells. J Biol Chem, 277, 30551-58.
212. Ratziu, V., Lalazar, A., Wong, L., Dang, Q., Collins, C., Shaulian, E., Jensen, S. and Friedman, S.L. (1998) Zf9, a Kruppel-like transcription factor up-regulated in vivo during early hepatic fibrosis. Proc Natl Acad Sci U S A, 95, 9500-5.
213. Kim, Y., Ratziu, V., Choi, S.G., Lalazar, A., Theiss, G., Dang, Q., Kim, S.J. and Friedman, S.L. (1998) Transcriptional activation of transforming growth factor beta1 and its receptors by the Kruppel-like factor Zf9/core promoter-binding protein and Sp1. Potential mechanisms for autocrine fibrogenesis in response to injury. J Biol Chem, 273, 33750-58.
214. Stärkel, P., Sempoux, C., Leclercq, I., Herin, M., Deby, C., Desager, J.P. and Horsmans, Y. (2003) Oxidative stress, KLF6 and transforming growth factor-beta up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats. J Hepatol, 39, 538-46.
215. Schnabl, B., Hu, K., Mühlbauer, M., Hellerbrand, C., Stefanovic, B., Brenner, D.A. and Schölmerich, J. (2005) Zinc finger protein 267 is up-regulated during the activation process of human hepatic stellate cells and functions as a negative transcriptional regulator of MMP-10. Biochem Biophys Res Commun, 335, 87-96.
216. Wang, X., Tang, X., Gong, X., Albanis, E., Friedman, S.L. and Mao, Z. (2004) Regulation of hepatic stellate cell activation and growth by transcription factor myocyte enhancer factor 2. Gastroenterology, 127, 1174-88.
217. Elsharkawy, A.M., Wright, M.C., Hay, R.T., Arthur, M.J., Hughes, T., Bahr, M.J., Degitz, K. and Mann, D.A. (1999) Persistent activation of nuclear factor-kappaB in cultured rat hepatic stellate cells involves the induction of potentially novel Rel-like factors and prolonged changes in the expression of IkappaB family proteins. Hepatology, 30, 761-69.
218. Rippe, R.A., Schrum, L.W., Stefanovic, B., Solís-Herruzo, J.A. and Brenner, D.A. (1999) NFkappaB inhibits expression of the alpha1(I) collagen gene. DNA Cell Biol, 18, 751-61.
219. Lang, A., Schoonhoven, R., Tuvia, S., Brenner, D.A. and Rippe, R.A. (2000) Nuclear factor kappaB in proliferation, activation, and apoptosis in rat hepatic stellate cells. J Hepatol, 33, 49-58.
220. Vasiliou, V., Lee, J., Pappa, A. and Petersen, D.R. (2000) Involvement of p65 in the regulation of NF-kappaB in rat hepatic stellate cells during cirrhosis. Biochem Biophys Res Commun, 273, 546-50.
221. Schwabe, R.F., Schnabl, B., Kweon, Y.O. and Brenner, D.A. (2001) CD40 activates NF-kappa B and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells. J Immunol, 166, 6812-19.
222. Novitskiy, G., Potter, J.J., Rennie-Tankersley, L. and Mezey, E. (2004) Identification of a novel NF-kappaB-binding site with regulation of the murine alpha2(I) collagen promoter. J Biol Chem, 279, 15639-44.
223. Oakley, F., Meso, M., Iredale, J.P., Green, K., Marek, C.J., Zhou, X., May, M.J., Millward-Sadler, H., Wright, M.C. and Mann, D.A. (2005) Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis. Gastroenterology, 128, 108-20.
224. Oakley, F., Mann, J., Nailard, S., Smart, D.E., Mungalsingh, N., Constandinou, C., Ali, S., Wilson, S.J., Millward-Sadler, H., Iredale, J.P. and Mann, D.A. (2005) Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury. Am J Pathol, 166, 695-708.
225. Thirunavukkarasu, C., Watkins, S.C. and Gandhi, C.R. (2006) Mechanisms of endotoxin-induced NO, IL-6, and TNF-alpha production in activated rat hepatic stellate cells: role of p38 MAPK. Hepatology, 44, 389-98.
226. Son, G., Iimuro, Y., Seki, E., Hirano, T., Kaneda, Y. and Fujimoto, J. (2007) Selective inactivation of NF-kappaB in the liver using NF-kappaB decoy suppresses CCl4-induced liver injury and fibrosis. Am J Physiol Gastrointest Liver Physiol, 293, G631-39.
227. Galli, A., Crabb, D., Price, D., Ceni, E., Salzano, R., Surrenti, C. and Casini, A. (2000) Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells. Hepatology, 31, 101-8.
228. Marra, F., Efsen, E., Romanelli, R.G., Caligiuri, A., Pastacaldi, S., Batignani, G., Bonacchi, A., Caporale, R., Laffi, G., Pinzani, M. and Gentilini, P. (2000) Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterology, 119, 466-78.
229. Miyahara, T., Schrum, L., Rippe, R., Xiong, S., Yee, H.F. Jr., Motomura, K., Anania, F.A., Willson, T.M. and Tsukamoto, H. (2000) Peroxisome proliferatoractivated receptors and hepatic stellate cell activation. J Biol Chem, 275, 35715-22.
230. Galli, A., Crabb, D.W., Ceni, E., Salzano, R., Mello, T., Svegliati-Baroni, G., Ridolfi, F., Trozzi, L., Surrenti, C. and Casini, A. (2002) Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterology, 122, 1924-40.
231. She, H., Xiong, S., Hazra, S. and Tsukamoto, H. (2005) Adipogenic transcriptional regulation of hepatic stellate cells. J Biol Chem, 280, 4959-67.
232. Yang, L., Chan, C.C., Kwon, O.S., Liu, S., McGhee, J., Stimpson, S.A., Chen, L.Z., Harrington, W.W., Symonds, W.T. and Rockey, D.C. (2006) Regulation of peroxisome proliferator-activated receptor-gamma in liver fibrosis. Am J Physiol Gastrointest Liver Physiol, 291, G902-11.
233. Hazra, S., Xiong, S., Wang, J., Rippe, R.A., Krishna, V., Chatterjee, K. and Tsukamoto, H. (2004) Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells. J Biol Chem, 279, 11392-401.
234. Okuyama, H., Shimahara, Y., Kawada, N., Seki, S., Kristensen, D.B., Yoshizato, K., Uyama, N. and Yamaoka, Y. (2001) Regulation of cell growth by redoxmediated extracellular proteolysis of platelet-derived growth factor receptor beta. J Biol Chem, 276, 28274-80.
235. Ikeda, H., Yatomi, Y., Yanase, M., Satoh, H., Nishihara, A., Kawabata, M. and Fujiwara, K. (1998) Effects of lysophosphatidic acid on proliferation of stellate cells and hepatocytes in culture. Biochem Biophys Res Commun, 248, 436-40.
236. Hernández-Muñoz, R., Díaz-Muñoz, M., Suárez-Cuenca, J.A., Trejo-Solís, C., López, V., Sánchez-Sevilla, L., Yáñez, L. and De Sánchez, V.C. (2001) Adenosine reverses a preestablished CCl4-induced micronodular cirrhosis through enhancing collagenolytic activity and stimulating hepatocyte cell proliferation in rats. Hepatology, 34, 677-87.
237. Hashmi, A.Z., Hakim, W., Kruglov, E.A., Watanabe, A., Watkins, W., Dranoff, J.A. and Mehal, W.Z. (2007) Adenosine inhibits cytosolic calcium signals and chemotaxis in hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol, 292, G395-401.
238. Sohail, M.A., Hashmi, A.Z., Hakim, W., Watanabe, A., Zipprich, A., Groszmann, R.J., Dranoff, J.A., Torok, N.J. and Mehal, W.Z. (2008) Adenosine induces loss of actin stress fibers and inhibits contraction in hepatic stellate cells via Rho inhibition. Hepatology, 49 (1), 185-94.
239. Caligiuri, A., Bertolani, C., Guerra, C.T., Aleffi, S., Galastri, S., Trappoliere, M., Vizzutti, F., Gelmini, S., Laffi, G., Pinzani, M. and Marra, F. (2008) Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells. Hepatology, 47, 668-76.
240. Chan, E.S., Montesinos, M.C., Fernandez, P., Desai, A., Delano, D.L., Yee, H., Reiss, A.B., Pillinger, M.H., Chen, J.F., Schwarzschild, M.A., Friedman, S.L. and Cronstein, B.N. (2006) Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis. Br J Pharmacol, 148, 1144-55.
241. Che, J., Chan, E.S. and Cronstein, B.N. (2007) Adenosine A2A receptor occupancy stimulates collagen expression by hepatic stellate cells via pathways involving protein kinase A, Src, and extracellular signal-regulated kinases 1/2 signaling cascade or p38 mitogen-activated protein kinase signaling pathway. Mol Pharmacol, 72, 1626-36.
242. Weigle, D.S. (1997) Leptin and other secretory products of adipocytes modulate multiple physiological functions. Ann Endocrinol (Paris), 58, 132-36.
243. Goldstein, B.J. and Scalia, R. (2004) Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab, 89, 2563-68.
244. Potter, J.J., Womack, L., Mezey, E. and Anania, F.A. (1998) Transdifferentiation of rat hepatic stellate cells results in leptin expression. Biochem Biophys Res Commun, 244, 178-82.
245. Saxena, N.K., Ikeda, K., Rockey, D.C., Friedman, S.L. and Anania, F.A. (2002) Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice. Hepatology, 35, 762-71.
246. Saxena, N.K., Saliba, G., Floyd, J.J. and Anania, F.A. (2003) Leptin induces increased alpha2(I) collagen gene expression in cultured rat hepatic stellate cells. J Cell Biochem, 89, 311-20.
247. Cao, Q., Mak, K.M., Ren, C. and Lieber, C.S. (2004) Leptin stimulates tissue inhibitor of metalloproteinase-1 in human hepatic stellate cells: respective roles of the JAK/STAT and JAK-mediated H2O2-dependant MAPK pathways. J Biol Chem, 279, 4292-304.
248. Saxena, N.K., Titus, M.A., Ding, X., Floyd, J., Srinivasan, S., Sitaraman, S.V. and Anania, F.A. (2004) Leptin as a novel profibrogenic cytokine in hepatic stellate cells: mitogenesis and inhibition of apoptosis mediated by extracellular regulated kinase (Erk) and Akt phosphorylation. FASEB J, 18, 1612-14.
249. Lang, T., Ikejima, K., Yoshikawa, M., Enomoto, N., Iijima, K., Kitamura, T., Takei, Y. and Sato, N. (2004) Leptin facilitates proliferation of hepatic stellate cells through up-regulation of platelet-derived growth factor receptor. Biochem Biophys Res Commun, 323, 1091-95.
250. Cao, Q., Mak, K.M. and Lieber, C.S. (2007) Leptin represses matrix metalloproteinase-1 gene expression in LX2 human hepatic stellate cells. J Hepatol, 46, 124-33.
251. Schaefer, B., Rivas-Estilla, A.M., Meraz-Cruz, N., Reyes-Romero, M.A., Hernández Nazara, Z.H., Domínguez-Rosales, J.A., Schuppan, D., Greenwel, P. and Rojkind, M. (2003) Reciprocal modulation of matrix metalloproteinase-13 and type I collagen genes in rat hepatic stellate cells. Am J Pathol, 162, 1771-80.
252. Mahadev, K., Wu, X., Donnelly, S., Ouedraogo, R., Eckhart, A.D. and Goldstein, B.J. (2008) Adiponectin inhibits vascular endothelial growth factor-induced migration of human coronary artery endothelial cells. Cardiovasc Res, 78, 376-84.
253. Wang, Y., Lam, K.S., Xu, J.Y., Lu, G., Xu, L.Y., Cooper, G.J. and Xu, A. (2005) Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem, 280, 18341-47.
254. Adachi, M. and Brenner, D.A. (2008) High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphateactivated protein kinase. Hepatology, 47, 677-85.
255. Dooley, S., Delvoux, B., Streckert, M., Bonzel, L., Stopa, M., ten Dijke, P. and Gressner, A.M. (2001) Transforming growth factor beta signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. TGFbeta signal transduction during transdifferentiation of hepatic stellate cells. FEBS Lett, 502, 4-10.
256. Dooley, S., Streckert, M., Delvoux, B. and Gressner, A.M. (2001) Expression of Smads during in vitro transdifferentiation of hepatic stellate cells to myofibroblasts. Biochem Biophys Res Commun, 283, 554-62.
257. Tahashi, Y., Matsuzaki, K., Date, M., Yoshida, K., Furukawa, F., Sugano, Y., Matsushita, M., Himeno, Y., Inagaki, Y. and Inoue, K. (2002) Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury. Hepatology, 35 (1), 49-61.
258. Liu, C., Gaça, M.D., Swenson, E.S., Vellucci, V.F., Reiss, M. and Wells, R.G. (2003) Smads 2 and 3 are differentially activated by transforming growth factor-beta (TGF-beta) in quiescent and activated hepatic stellate cells. Constitutive nuclear localization of Smads in activated cells is TGF-beta-independent. J BiolChem, 278 (13), 11721-28.
259. Wakahara, K., Kobayashi, H., Yagyu, T., Matsuzaki, H., Kondo, T., Kurita, N., Sekino, H., Inagaki, K., Suzuki, M., Kanayama, N. and Terao, T. (2004) Transforming growth factor-beta1-dependent activation of Smad2/3 and up-regulation of PAI-1 expression is negatively regulated by Src in SKOV-3 human ovarian cancer cells. J Cell Biochem, 93, 437-53.
260. Greenwel, P. (1999) Acetaldehyde-mediated collagen regulation in hepatic stellate cells. Alcohol Clin Exp Res, 23 (5), 930-33.
261. Bataller, R., Schwabe, R.F., Choi, Y.H., Yang, L., Paik, Y.H., Lindquist, J., Qian, T., Schoonhoven, R., Hagedorn, C.H., Lemasters, J.J. and Brenner, D.A. (2003) NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest, 112, 1383-94.
262. Adachi, T., Togashi, H., Suzuki, A., Kasai, S., Ito, J., Sugahara, K. and Kawata, S. (2005) NAD(P)H oxidase plays a crucial role in PDGF-induced proliferation of hepatic stellate cells. Hepatology, 41, 1272-81.
263. Pérez de Obanos, M.P., López-Zabalza, M.J., Arriazu, E., Modol, T., Prieto, J., Herraiz, M.T. and Iraburu, M.J. (2007) Reactive oxygen species (ROS) mediate the effects of leucine on translation regulation and type I collagen production in hepatic stellate cells. Biochim Biophys Acta, 1773, 1681-88.
264. De Minicis, S. and Brenner, D.A. (2008) Oxidative stress in alcoholic liver disease: role of NADPH oxidase complex. Gastroenterol Hepatol, 23 (Suppl 1), S98-103.
265. De Minicis, S. and Brenner, D.A. (2007) NOX in liver fibrosis. Arch Biochem Biophys, 462, 266-72.
266. De Minicis, S., Seki, E., Oesterreicher, C., Schnabl, B., Schwabe, R.F. and Brenner, D.A. (2008) Reduced nicotinamide adenine dinucleotide phosphate oxidase mediates fibrotic and inflammatory effects of leptin on hepatic stellate cells. Hepatology, 48, 2016-26.
267. Clouzeau-Girard, H., Guyot, C., Combe, C., Moronvalle-Halley, V., Housset, C., Lamireau, T., Rosenbaum, J. and Desmoulière, A. (2006) Effects of bile acids on biliary epithelial cell proliferation and portal fibroblast activation using rat liver slices. Lab Invest, 86, 275-85.
268. Myung, S.J., Yoon, J.H., Gwak, G.Y., Kim, W., Yang, J.I., Lee, S.H., Jang, J.J. and Lee, H.S. (2007) Bile acid-mediated thrombospondin-1 induction in hepatocytes leads to transforming growth factor-beta-dependent hepatic stellate cell activation. Biochem Biophys Res Commun, 353, 1091-96.
269. Murphy-Ullrich, J.E. and Poczatek, M. (2000) Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology. Cytokine Growth Factor Rev, 11, 59-69.
270. Ohara, F., Nii, A., Sakiyama, Y., Tsuchiya, M. and Ogawa, S. (2008) Pathophysiological characteristics of dimethylnitrosamine-induced liver fibrosis in acute and chronic injury models: a possible contribution of KLF5 to fibrogenic responses. Dig Dis Sci, 53, 2222-32.
271. Chen, A. and Davis, B.H. (2000) The DNA binding protein BTEB mediates acetaldehyde-induced, jun N-terminal kinase-dependent alphaI(I) collagen gene expression in rat hepatic stellate cells. Mol Cell Biol, 20, 2818-26.
272. Tajima, K., Terai, S., Takami, T., Kawaguchi, K., Okita, K. and Sakaida, I. (2007) Importance of inhibitor of DNA binding/differentiation 2 in hepatic stellate cell differentiation and proliferation. Hepatol Res, 37, 647-55.
273. Tsukamoto, H., She, H., Hazra, S., Cheng, J. and Miyahara, T. (2006) Anti-adipogenic regulation underlies hepatic stellate cell transdifferentiation. J Gastroenterol Hepatol, 21, S102-5.
274. Geerts, A., Greenwel, P., Cunningham, M., De Bleser, P., Rogiers, V., Wisse, E. and Rojkind, M. (1993) Identification of connective tissue gene transcripts in freshly isolated parenchymal, endothelial, Kupffer and fat-storing cells by northern hybridization analysis. J Hepatol, 19, 148-58.
275. Leclercq, I.A., Sempoux, C., Stärkel, P. and Horsmans, Y. (2006) Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats. Gut, 55, 1020-29.
276. Yavrom, S., Chen, L., Xiong, S., Wang, J., Rippe, R.A. and Tsukamoto, H. (2005) Peroxisome proliferator-activated receptor gamma suppresses proximal alpha1(I) collagen promoter via inhibition of p300-facilitated NF-I binding to DNA in hepatic stellate cells. J Biol Chem, 280, 40650-59.
277. Ceni, E., Crabb, D.W., Foschi, M., Mello, T., Tarocchi, M., Patussi, V., Moraldi, L., Moretti, R., Milani, S., Surrenti, C. and Galli, A. (2006) Acetaldehyde inhibits PPARgamma via H2O2-mediated c-Abl activation in human hepatic stellate cells. Gastroenterology, 131, 1235-52.
278. Planagumà, A., Clària, J., Miquel, R., López-Parra, M., Titos, E., Masferrer, J.L., Arroyo, V. and Rodés, J. (2005) The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation. FASEB J, 19, 1120-22.
279. Marra, F., DeFranco, R., Robino, G., Novo, E., Efsen, E., Pastacaldi, S., Zamara, E., Vercelli, A., Lottini, B., Spirli, C., Strazzabosco, M., Pinzani, M. and Parola, M. (2005) Thiazolidinedione treatment inhibits bile duct proliferation and fibrosis in a rat model of chronic cholestasis. World J Gastroenterol, 11, 4931-38.
280. Bruck, R., Weiss, S., Aeed, H., Pines, M., Halpern, Z. and Zvibel, I. (2008) Additive inhibitory effect of experimentally induced hepatic cirrhosis by agonists of peroxisome proliferator activator receptor gamma and retinoic acid receptor. Dig Dis Sci, 54 (2), 292-9.
281. Fiorucci, S., Rizzo, G., Antonelli, E., Renga, B., Mencarelli, A., Riccardi, L., Morelli, A., Pruzanski, M. and Pellicciari, R. (2005) Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor gamma contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis. J Pharmacol Exp Ther, 315, 58-68.
282. Zheng, S. and Chen, A. (2006) Curcumin suppresses the expression of extracellular matrix genes in activated hepatic stellate cells by inhibiting gene expression of connective tissue growth factor. Am J Physiol Gastrointest Liver Physiol, 290, G883-93.
283. Zheng, S. and Chen, A. (2004) Activation of PPARgamma is required for curcumin to induce apoptosis and to inhibit the expression of extracellular matrix genes in hepatic stellate cells in vitro. Biochem J, 384, 149-57.
284. Zheng, S. and Chen, A. (2007) Disruption of transforming growth factor-beta signaling by curcumin induces gene expression of proliferator-activated receptor-gamma in rat hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol, 292, G113-23.
285. Zhou, Y., Zheng, S., Lin, J., Zhang, Q.J. and Chen, A. (2007) The interruption of the PDGF and EGF signaling pathways by curcumin stimulates gene expression of PPARgamma in rat activated hepatic stellate cell in vitro. Lab Invest, 87, 488-98.
286. Lin, J. and Chen, A. (2008) Activation of peroxisome proliferator-activated receptor-gamma by curcumin blocks the signaling pathways for PDGF and EGF in hepatic stellate cells. Lab Invest, 88, 529-40.
287. Fu, Y., Zheng, S., Lin, J., Ryerse, J. and Chen, A. (2008) Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Mol Pharmacol, 73, 399-409.
288. van Amerongen, R., Mikels, A. and Nusse, R. (2008) Alternative wnt signaling is initiated by distinct receptors. Sci Signal, 1, re9.
289. Grigoryan, T., Wend, P., Klaus, A. and Birchmeier, W. (2008) Deciphering the function of canonical Wnt signals in development and disease: conditional lossand gain-of-function mutations of beta-catenin in mice. Genes Dev, 22, 2308-41.
290. Katoh, M. (2008) WNT signaling in stem cell biology and regenerative medicine. Curr Drug Targets, 9, 565-70.
291. Coombs, G.S., Covey, T.M. and Virshup, D.M. (2008) Wnt signaling in development, disease and translational medicine (Review). Curr Drug Targets, 9 (7), 513-31.
292. Nusse, R. (2008) Wnt signaling and stem cell control. Cell Res, 18, 523-527.
293. Hendrickx, M. and Leyns, L. (2008) Non-conventional Frizzled ligands and Wnt receptors. Dev Growth Differ, 50, 229-43.
294. Jiang, F., Parsons, C.J. and Stefanovic, B. (2006) Gene expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signaling pathway in activation. J Hepatol, 45, 401-9.
295. Kordes, C., Sawitza, I. and Häussinger, D. (2008) Canonical Wnt signaling maintains the quiescent stage of hepatic stellate cells. Biochem Biophys Res Commun, 367, 116-23.
296. Myung, S.J., Yoon, J.H., Gwak, G.Y., Kim, W., Lee, J.H., Kim, K.M., Shin, C.S., Jang, J.J., Lee, S.H., Lee, S.M. and Lee, H.S. (2007) Wnt signaling enhances the activation and survival of human hepatic stellate cells. FEBS Lett, 581, 2954-58.
297. Cheng, J.H., She, H., Han, Y.P., Wang, J., Xiong, S., Asahina, K. and Tsukamoto, H. (2008) Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis. Am J Physiol Gastrointest Liver Physiol, 294, G39-49.
298. Thompson, M.D. and Monga, S.P. (2007) WNT/betacatenin signaling in liver health and disease. Hepatology, 45, 1298-305.
299. Varjosalo, M. and Taipale, J. (2008) Hedgehog: functions and mechanisms. Genes Dev, 22, 2454-72.
300. Sicklick, J.K., Li, Y.X., Choi, S.S., Qi, Y., Chen, W., Bustamante, M., Huang, J., Zdanowicz, M., Camp, T., Torbenson, M.S., Rojkind, M. and Diehl, A.M. (2005) Role for hedgehog signaling in hepatic stellate cell activation and viability. Lab Invest, 85, 1368-80.
301. Omenetti, A., Popov, Y., Jung, Y., Choi, S.S., Witek, R.P., Yang, L., Brown, K.D., Schuppan, D. and Diehl, A.M. (2008) The hedgehog pathway regulates remodelling responses to biliary obstruction in rats. Gut, 57, 1275-82.
302. Omenetti, A. and Diehl, A.M. (2008) The adventures of sonic hedgehog in development and repair. II. Sonic hedgehog and liver development, inflammation, and cancer. Am J Physiol Gastrointest Liver Physiol, 294, G595-98.
303. Yang, L., Wang, Y., Mao, H., Fleig, S., Omenetti, A., Brown, K.D., Sicklick, J.K., Li, Y.X. and Diehl, A.M. (2008) Sonic hedgehog is an autocrine viability factor for myofibroblastic hepatic stellate cells. J Hepatol, 48, 98-106.
304. Omenetti, A., Porrello, A., Jung, Y., Yang, L., Popov, Y., Choi, S.S., Witek, R.P., Alpini, G., Venter, J., Vandongen, H.M., Syn, W.K., Baroni, G.S., Benedetti, A., Schuppan, D. and Diehl, A.M. (2008) Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans. J Clin Invest, 118, 3331-42.
305. Katoh, Y. and Katoh, M. (2008) Hedgehog signaling, epithelial-to-mesenchymal transition and miRNA (review). Int J Mol Med, 22, 271-75.
306. Hines, I.N. and Rippe, R.A. (2008) Role of hedgehog signalling in bile ductular cells. Gut, 57, 1198-99.
307. Wells, R.G. (2005) The role of matrix stiffness in hepatic stellate cell activation and liver fibrosis. J Clin Gastroenterol, 39 (4 Suppl 2), S158-61.
308. Georges, P.C., Hui, J.J., Gombos, Z., McCormick, M.E., Wang, A.Y., Uemura, M., Mick, R., Janmey, P.A., Furth, E.E. and Wells, R.G. (2007) Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis. Am J Physiol Gastrointest Liver Physiol, 293, G1147-54.
309. Li, Z., Dranoff, J.A., Chan, E.P., Uemura, M., Sévigny, J. and Wells, R.G. (2007) Transforming growth factor-beta and substrate stiffness regulate portal fibroblast activation in culture. Hepatology, 46, 1246-56.
310. Wells, R.G. (2008) The role of matrix stiffness in regulating cell behavior. Hepatology, 47, 1394-400.
311. Henderson, N.C., Mackinnon, A.C., Farnworth, S.L., Poirier, F., Russo, F.P., Iredale, J.P., Haslett, C., Simpson, K.J. and Sethi, T. (2006) Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci U S A, 103, 5060-65.
312. Vater, C.A., Harris, E.D. Jr. and Siegel, R.C. (1979) Native cross-links in collagen fibrils induce resistance to human synovial collagenase. Biochem J, 181, 639-45.
313. van der Slot-Verhoeven, A.J., van Dura, E.A., Attema, J., Blauw, B., Degroot, J., Huizinga, T.W., Zuurmond, A.M. and Bank, R.A. (2005) The type of collagen cross-link determines the reversibility of experimental skin fibrosis. Biochim Biophys Acta, 1740, 60-67.
314. Rojkind, M., Rojkind, M.H. and Cordero-Hernández, J. (1983) In vivo collagen synthesis and deposition in fibrotic and regenerating rat livers. Coll Relat Res, 3, 335-47.
315. Wells, R.G. and Discher, D.E. (2008) Matrix elasticity, cytoskeletal tension, and TGF-beta: the insoluble and soluble meet. Sci Signal, 1, pe13.
316. Rojkind, M. (1999) Role of metalloproteinases in liver fibrosis. Alcohol Clin Exp Res, 23, 934-39.
317. Zhan, S.S., Jiang, J.X., Wu, J., Halsted, C., Friedman, S.L., Zern, M.A. and Torok, N.J. (2006) Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo. Hepatology, 43, 435-43.
318. Muhanna, N., Doron, S., Wald, O., Horani, A., Eid, A., Pappo, O., Friedman, S.L. and Safadi, R. (2008) Activation of hepatic stellate cells after phagocytosis of lymphocytes: A novel pathway of fibrogenesis. Hepatology, 48, 963-77.
319. Jiang, J.X., Mikami, K., Shah, V.H. and Torok, N.J. (2008) Leptin induces phagocytosis of apoptotic bodies by hepatic stellate cells via a Rho guanosine triphosphatase-dependent mechanism. Hepatology, 48, 1497-505.
320. Viñas, O., Bataller, R., Sancho-Bru, P., Ginès, P., Berenguer, C., Enrich, C., Nicolás, J.M., Ercilla, G., Gallart, T., Vives, J., Arroyo, V. and Rodés, J. (2003) Human hepatic stellate cells show features of antigenpresenting cells and stimulate lymphocyte proliferation. Hepatology, 38, 919-29.
321. Holt, A.P., Haughton, E.L., Lalor, P.F., Filer, A., Buckley, C.D. and Adams, D.H. (2009) Liver myofibroblasts regulate infiltration and positioning of lymphocytes in human liver. Gastroenterology, 136 (2), 705-14.
322. Muhanna, N., Horani, A., Doron, S. and Safadi, R. (2007) Lymphocyte-hepatic stellate cell proximity suggests a direct interaction. Clin Exp Immunol, 148, 338-47.
323. Wang, Y.Q., Luk, J.M., Ikeda, K., Man, K., Chu, A.C., Kaneda, K. and Fan, S.T. (2004) Regulatory role of vHL/HIF-1alpha in hypoxia-induced VEGF production in hepatic stellate cells. Biochem Biophys Res Commun, 317, 358-62.
324. Shi, Y.F., Fong, C.C., Zhang, Q., Cheung, P.Y., Tzang, C.H., Wu, R.S. and Yang, M. (2007) Hypoxia induces the activation of human hepatic stellate cells LX-2 through TGF-beta signaling pathway. FEBS Lett, 581, 203-10.
325. Novo, E., Cannito, S., Zamara, E., Valfrè di Bonzo, L., Caligiuri, A., Cravanzola, C., Compagnone, A., Colombatto, S., Marra, F., Pinzani, M. and Parola, M. (2007) Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells. Am J Pathol, 170, 1942-53.
326. Hirota, K. and Semenza, G.L. (2005) Regulation of hypoxia-inducible factor 1 by prolyl and asparaginyl hydroxylases. Biochem Biophys Res Commun, 338, 610-16.
327. Semenza, G.L. (2006) Regulation of physiological responses to continuous and intermittent hypoxia by hypoxia-inducible factor 1. Exp Physiol, 91, 803-6.
328. Ke, Q. and Costa, M. (2006) Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol, 70, 1469-80.
329. Iredale, J.P., Benyon, R.C., Pickering, J., McCullen, M., Northrop, M., Pawley, S., Hovell, C. and Arthur, M.J. (1998) Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest, 102, 538-49.
330. Issa, R., Williams, E., Trim, N., Kendall, T., Arthur, M.J., Reichen, J., Benyon, R.C. and Iredale, J.P. (2001) Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors. Gut, 48, 548-57.
331. Elsharkawy, A.M., Oakley, F. and Mann, D.A. (2005) The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis, 10, 927-39.
332. Watson, M.R., Wallace, K., Gieling, R.G., Manas, D.M., Jaffray, E., Hay, R.T., Mann, D.A. and Oakley, F. (2008) NF-kappaB is a critical regulator of the survival of rodent and human hepatic myofibroblasts. J Hepatol, 48, 589-97.
333. Fiorucci, S., Rizzo, G., Antonelli, E., Renga, B., Mencarelli, A., Riccardi, L., Orlandi, S., Pruzanski, M., Morelli, A. and Pellicciari, R. (2005) A farnesoid x receptor-small heterodimer partner regulatory cascade modulates tissue metalloproteinase inhibitor-1 and matrix metalloprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis. J Pharmacol Exp Ther, 314, 584-95.
334. Issa, R., Zhou, X., Constandinou, C.M., Fallowfield, J., Millward-Sadler, H., Gaca, M.D., Sands, E., Suliman, I., Trim, N., Knorr, A., Arthur, M.J., Benyon, R.C. and Iredale, J.P. (2004) Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking. Gastroenterology, 126, 1795-808.
335. Oakley, F., Meso, M., Iredale, J.P., Green, K., Marek, C.J., Zhou, X., May, M.J., Millward-Sadler, H., Wright, M.C. and Mann, D.A. (2005) Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis. Gastroenterology, 128, 108-20.
336. Friedman, S.L., Roll, F.J., Boyles, J., Arenson, D.M. and Bissell, D.M. (1989) Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix. J Biol Chem, 264, 10756-62.
337. Jarnagin, W.R., Rockey, D.C., Koteliansky, V.E., Wang, S.S. and Bissell, D.M. (1994) Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol, 127, 2037-48.
338. Ramadori, G. and Saile, B. (2002) Mesenchymal cells in the liver-one cell type or two? Liver, 22, 283-94.
339. Ramadori, G. and Saile, B. (2004) Portal tract fibrogenesis in the liver. Lab Invest, 84 (2), 153-59.
340. Gumucio, J.J. (1989) Hepatocyte heterogeneity: the coming of age from the description of a biological curiosity to a partial understanding of its physiological meaning and regulation. Hepatology, 9, 154-60.
341. Groothuis, G.M. and Meijer, D.K. (1992) Hepatocyte heterogeneity in bile formation and hepatobiliary transport of drugs. Enzyme, 46, 94-138.
342. Quistorff, B., Katz, N. and Witters, L.A. (1992) Hepatocyte heterogeneity in the metabolism of fatty acids: discrepancies on zonation of acetyl-CoA carboxylase. Enzyme, 46, 59-71.
343. Jungermann, K. and Thurman, R.G. (1992) Hepatocyte heterogeneity in the metabolism of carbohydrates. Enzyme, 46, 33-58.
344. Sell, S. (2001) Heterogeneity and plasticity of hepatocyte lineage cells. Hepatology, 33, 738-50.
345. Sell, S. (2003) The hepatocyte: heterogeneity and plasticity of liver cells. Int J Biochem Cell Biol, 35, 267-71.
346. Kisseleva, T. and Brenner, D.A. (2008) Fibrogenesis of parenchymal organs. Proc Am Thorac Soc, 5, 338-42.
347. Das, S.K. and Vasudevan, D.M. (2008) Genesis of hepatic fibrosis and its biochemical markers. Scand J Clin Lab Invest, 68, 260-69.
348. Gressner, A.M. (1983) Hepatic proteoglycans-a brief survey of their pathobiochemical implications. Hepatogastroenterology, 30, 225-29.
349. Gressner, A.M., Krull, N. and Bachem, M.G. (1994) Regulation of proteoglycan expression in fibrotic liver and cultured fat-storing cells. Pathol Res Pract, 190, 864-82.
350. Gressner, A.M. (1994) Activation of proteoglycan synthesis in injured liver-a brief review of molecular and cellular aspects. Eur J Clin Chem Clin Biochem, 32, 225-37.
351. Krull, N.B., Zimmermann, T. and Gressner, A.M. (1993) Spatial and temporal patterns of gene expression for the proteoglycans biglycan and decorin and for transforming growth factor-beta 1 revealed by in situ hybridization during experimentally induced liver fibrosis in the rat. Hepatology, 18, 581-89.
352. Gressner, A.M. (1994) Activation of proteoglycan synthesis in injured liver-a brief review of molecular and cellular aspects. Eur J Clin Chem Clin Biochem, 32, 225-37.
353. Rojkind, M., Giambrone, M.A. and Biempica, L. (1979) Collagen types in normal and cirrhotic liver. Gastroenterology, 76 (4), 710-19.
354. Biempica, L., Dunn, M.A., Kamel, I.A., Kamel, R., Hait, P.K., Fleischner, C., Biempica, S.L., Wu, C.H. and Rojkind, M. (1983) Liver collagen-type characterization in human schistosomiasis. A histological, ultrastructural, and immunocytochemical correlation. Am J Trop Med Hyg, 32, 316-25.
355. van der Slot, A.J., Zuurmond, A.M., van den Bogaerdt, A.J., Ulrich, M.M., Middelkoop, E., Boers, W., Karel Ronday, H., DeGroot, J., Huizinga, T.W. and Bank, R.A. (2004) Increased formation of pyridinoline cross-links due to higher telopeptide lysyl hydroxylase levels is a general fibrotic phenomenon. Matrix Biol, 23, 251-57.
356. Robins, S.P. (2007) Biochemistry and functional significance of collagen cross-linking. Biochem Soc Trans, 35, 849-52.
357. Zhou, X., Hovell, C.J., Pawley, S., Hutchings, M.I., Arthur, M.J., Iredale, J.P. and Benyon, R.C. (2004) Expression of matrix metalloproteinase-2 and -14 persists during early resolution of experimental liver fibrosis and might contribute to fibrolysis. Liver Int, 24, 492-501.
358. Zhou, X., Jamil, A., Nash, A., Chan, J., Trim, N., Iredale, J.P. and Benyon, R.C. (2006) Impaired proteolysis of collagen I inhibits proliferation of hepatic stellate cells: implications for regulation of liver fibrosis. J Biol Chem, 281, 39757-65.
359. Pérez-Tamayo, R. (1979) Cirrhosis of the liver: a reversible disease? Pathol Annu, 14, 183-213.
360. Rojkind, M. and Dunn, M.A. (1979) Hepatic fibrosis. Gastroenterology, 76, 849-63.
361. Falize, L., Guillygomarc’h, A., Perrin, M., Lainé, F., Guyader, D., Brissot, P., Turlin, B. and Deugnier, Y. (2006) Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases. Hepatology, 4, 72-77.
362. Maylin, S., Martinot-Peignoux, M., Moucari, R., Boyer, N., Ripault, M.P., Cazals-Hatem, D., Giuily, N., Castelnau, C., Cardoso, A.C., Asselah, T., Féray, C., Nicolas-Chanoine, M.H., Bedossa, P. and Marcellin, P. (2008) Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C. Gastroenterology, 135, 821-29.
363. Knittel, T., Mehde, M., Kobold, D., Saile, B., Dinter, C. and Ramadori, G. (1999) Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-alpha and TGF-beta1. J Hepatol, 30, 48-60.
364. Benyon, R.C., Hovell, C.J., Da Gaça, M., Jones, E.H., Iredale, J.P. and Arthur, M.J. (1999) Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation. Hepatology, 30, 977-86.
365. Knittel, T., Mehde, M., Grundmann, A., Saile, B., Scharf, J.G. and Ramadori, G. (2000) Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat. Histochem Cell Biol, 113, 443-53.
366. Arthur, M.J. (2000) Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis. Am J Physiol Gastrointest Liver Physiol, 279, G245-49.
367. Benyon, R.C. and Arthur, M.J. (2001) Extracellular matrix degradation and the role of hepatic stellate cells. Semin Liver Dis, 21, 373-84.
368. Murphy, F.R., Issa, R., Zhou, X., Ratnarajah, S., Nagase, H., Arthur, M.J., Benyon, C. and Iredale, J.P. (2002) Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis. J Biol Chem, 277 (13), 11069-76.
369. Lechuga, C.G., Hernández-Nazara, Z.H., Domínguez Rosales, J.A., Morris, E.R., Rincón, A.R., Rivas-Estilla, A.M., Esteban-Gamboa, A. and Rojkind, M. (2004) TGF-beta1 modulates matrix metalloproteinase-13 expression in hepatic stellate cells by complex mechanisms involving p38MAPK, PI3-kinase, AKT, and p70S6k. Am J Physiol Gastrointest Liver Physiol, 287, G974-87.
370. de la Torre, P., Díaz-Sanjuán, T., García-Ruiz, I., Esteban, E., Canga, F., Muñoz-Yagüe, T. and Solís-Herruzo, J.A. (2005) Interleukin-6 increases rat metalloproteinase-13 gene expression through Janus kinase-2-mediated inhibition of serine/threonine phosphatase-2A. Cell Signal, 17, 427-35.
371. Arthur, M.J., Iredale, J.P. and Mann, D.A. (1999) Tissue inhibitors of metalloproteinases: role in liver fibrosis and alcoholic liver disease. Alcohol Clin Exp Res, 23, 940-43.
372. Han, Y.P., Yan, C., Zhou, L., Qin, L. and Tsukamoto, H. (2007) A matrix metalloproteinase-9 activation cascade by hepatic stellate cells in trans-differentiation in the three-dimensional extracellular matrix. J Biol Chem, 282, 12928-39.
373. Seomun, Y., Kim, J.T. and Joo, C.K. (2008) MMP-14 mediated MMP-9 expression is involved in TGF-beta1-induced keratinocyte migration. J Cell Biochem, 104, 934-41.